We are live on ! Find out more
TMH

Team Health Holdings Inc
TMH

Delisted

TMH was delisted on the 3rd of February, 2017.

0 hedge funds and large institutions have $0 invested in Team Health Holdings Inc in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 20 (-2)

100% less capital invested

Capital invested by funds: $12.8M → $0 (-$12.8M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
Holders Change
-2
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
1
Pennant Capital Management
New Jersey
-$9.15M -1,158,131 Closed
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
-$3.64M -460,000 Closed

TMH Hedge Fund Activity: Q2 2018 in Review

0 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Team Health Holdings Inc (TMH) for Q2 2018, worth a combined $0 — down 100% from $12.8M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TMH and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pennant Capital Management, exiting entirely with an estimated $9.15M sold.

  • 0 institutional investors held Team Health Holdings Inc (TMH) as of Q2 2018, down from 2 in Q1 2018.
  • Funds reported $0 of Team Health Holdings Inc stock for Q2 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Team Health Holdings Inc positions in Q2 2018 and 2 closed out, a net change of -2 holders.
  • The largest Team Health Holdings Inc seller in Q2 2018 was Pennant Capital Management, an estimated $9.15M sold.

Based on aggregated 13F filings for Q2 2018.